APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gliflozin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gliflozin Market Analysis and Forecast 2026-2032

31 December 2025192 pages

Choose your research edition.

Industry ResearchGliflozin Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Gliflozin Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Gliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gliflozin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gliflozin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Gliflozin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gliflozin include Janssen Pharmaceutical, Merck, Eli Lilly, Pfizer, AstraZeneca, Boehringer Ingelheim and Astellas Pharma Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gliflozin, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gliflozin, also provides the revenue of main regions and countries. Of the upcoming market potential for Gliflozin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gliflozin revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gliflozin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gliflozin revenue, projected growth trends, production technology, application and end-user industry.

Gliflozin Segment by Company

Janssen Pharmaceutical

Merck

Eli Lilly

Pfizer

AstraZeneca

Boehringer Ingelheim

Astellas Pharma Inc.

Gliflozin Segment by Type

Dapagliflozin

Empagliflozin

Canagliflozin

Other

Gliflozin Segment by Application

Hospital

Clinic

Other

Gliflozin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliflozin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gliflozin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliflozin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gliflozin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gliflozin company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gliflozin revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gliflozin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Dapagliflozin Major Player Table 3. Empagliflozin Major Player Table 4. Canagliflozin Major Player Table 5. Other Major Player Table 6. Global Gliflozin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Clinic Major Player Table 9. Other Major Player Table 10. Gliflozin Industry Trends Table 11. Gliflozin Industry Drivers Table 12. Gliflozin Industry Opportunities and Challenges Table 13. Gliflozin Industry Restraints Table 14. Global Gliflozin Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Gliflozin Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Gliflozin Market Share by Region (2021-2026) Table 17. Global Gliflozin Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Gliflozin Market Share by Region (2027-2032) Table 19. Global Gliflozin Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Gliflozin Revenue Market Share by Players (2021-2026) Table 21. Global Gliflozin Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Gliflozin Key Players Headquarters & Area Served Table 23. Global Gliflozin Players, Product Type & Application Table 24. Global Gliflozin Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Gliflozin by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Gliflozin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Gliflozin Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Gliflozin Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Gliflozin Revenue Market Share by Type (2021-2026) Table 31. Global Gliflozin Revenue Market Share by Type (2027-2032) Table 32. Global Gliflozin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Gliflozin Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Gliflozin Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Gliflozin Revenue Market Share by Application (2021-2026) Table 36. Global Gliflozin Revenue Market Share by Application (2027-2032) Table 37. Janssen Pharmaceutical Company Information Table 38. Janssen Pharmaceutical Business Overview Table 39. Janssen Pharmaceutical Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Janssen Pharmaceutical Gliflozin Product Portfolio Table 41. Janssen Pharmaceutical Recent Development Table 42. Merck Company Information Table 43. Merck Business Overview Table 44. Merck Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Merck Gliflozin Product Portfolio Table 46. Merck Recent Development Table 47. Eli Lilly Company Information Table 48. Eli Lilly Business Overview Table 49. Eli Lilly Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Eli Lilly Gliflozin Product Portfolio Table 51. Eli Lilly Recent Development Table 52. Pfizer Company Information Table 53. Pfizer Business Overview Table 54. Pfizer Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Pfizer Gliflozin Product Portfolio Table 56. Pfizer Recent Development Table 57. AstraZeneca Company Information Table 58. AstraZeneca Business Overview Table 59. AstraZeneca Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. AstraZeneca Gliflozin Product Portfolio Table 61. AstraZeneca Recent Development Table 62. Boehringer Ingelheim Company Information Table 63. Boehringer Ingelheim Business Overview Table 64. Boehringer Ingelheim Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Boehringer Ingelheim Gliflozin Product Portfolio Table 66. Boehringer Ingelheim Recent Development Table 67. Astellas Pharma Inc. Company Information Table 68. Astellas Pharma Inc. Business Overview Table 69. Astellas Pharma Inc. Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Astellas Pharma Inc. Gliflozin Product Portfolio Table 71. Astellas Pharma Inc. Recent Development Table 72. North America Gliflozin Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Gliflozin Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Gliflozin Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Gliflozin Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Gliflozin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. North America Gliflozin Revenue by Country (2021-2026) & (US$ Million) Table 78. North America Gliflozin Revenue by Country (US$ Million) & (2027-2032) Table 79. Europe Gliflozin Revenue by Type (2021-2026) & (US$ Million) Table 80. Europe Gliflozin Revenue by Type (2027-2032) & (US$ Million) Table 81. Europe Gliflozin Revenue by Application (2021-2026) & (US$ Million) Table 82. Europe Gliflozin Revenue by Application (2027-2032) & (US$ Million) Table 83. Europe Gliflozin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Europe Gliflozin Revenue by Country (2021-2026) & (US$ Million) Table 85. Europe Gliflozin Revenue by Country (US$ Million) & (2027-2032) Table 86. China Gliflozin Revenue by Type (2021-2026) & (US$ Million) Table 87. China Gliflozin Revenue by Type (2027-2032) & (US$ Million) Table 88. China Gliflozin Revenue by Application (2021-2026) & (US$ Million) Table 89. China Gliflozin Revenue by Application (2027-2032) & (US$ Million) Table 90. Asia Gliflozin Revenue by Type (2021-2026) & (US$ Million) Table 91. Asia Gliflozin Revenue by Type (2027-2032) & (US$ Million) Table 92. Asia Gliflozin Revenue by Application (2021-2026) & (US$ Million) Table 93. Asia Gliflozin Revenue by Application (2027-2032) & (US$ Million) Table 94. Asia Gliflozin Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Asia Gliflozin Revenue by Region (US$ Million) & (2021-2026) Table 96. Asia Gliflozin Revenue by Region (US$ Million) & (2027-2032) Table 97. SAMEA Gliflozin Revenue by Type (2021-2026) & (US$ Million) Table 98. SAMEA Gliflozin Revenue by Type (2027-2032) & (US$ Million) Table 99. SAMEA Gliflozin Revenue by Application (2021-2026) & (US$ Million) Table 100. SAMEA Gliflozin Revenue by Application (2027-2032) & (US$ Million) Table 101. SAMEA Gliflozin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. SAMEA Gliflozin Revenue by Country (2021-2026) & (US$ Million) Table 103. SAMEA Gliflozin Revenue by Country (US$ Million) & (2027-2032) Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Gliflozin Image Figure 2. Global Gliflozin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gliflozin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Dapagliflozin Image Figure 5. Empagliflozin Image Figure 6. Canagliflozin Image Figure 7. Other Image Figure 8. Global Gliflozin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Gliflozin Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Other Image Figure 13. Global Gliflozin Market Size (US$ Million) & (2021-2032) Figure 14. Global Gliflozin Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Gliflozin Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Gliflozin Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Gliflozin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Gliflozin Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Gliflozin Revenue Market Share by Type (2021-2032) Figure 21. Global Gliflozin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Gliflozin Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Gliflozin Revenue Market Share by Application (2021-2032) Figure 24. North America Gliflozin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Gliflozin Revenue Share by Type (2021-2032) Figure 26. North America Gliflozin Revenue Share by Application (2021-2032) Figure 27. North America Gliflozin Revenue Share by Country (2021-2032) Figure 28. United States Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Gliflozin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Gliflozin Revenue Share by Type (2021-2032) Figure 33. Europe Gliflozin Revenue Share by Application (2021-2032) Figure 34. Europe Gliflozin Revenue Share by Country (2021-2032) Figure 35. Germany Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Gliflozin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Gliflozin Revenue Share by Type (2021-2032) Figure 45. China Gliflozin Revenue Share by Application (2021-2032) Figure 46. Asia Gliflozin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Gliflozin Revenue Share by Type (2021-2032) Figure 48. Asia Gliflozin Revenue Share by Application (2021-2032) Figure 49. Asia Gliflozin Revenue Share by Region (2021-2032) Figure 50. Japan Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Gliflozin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Gliflozin Revenue Share by Type (2021-2032) Figure 58. SAMEA Gliflozin Revenue Share by Application (2021-2032) Figure 59. SAMEA Gliflozin Revenue Share by Country (2021-2032) Figure 60. Brazil Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Gliflozin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Dapagliflozin
  • Empagliflozin
  • Canagliflozin
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Janssen Pharmaceutical
  • Merck
  • Eli Lilly
  • Pfizer
  • AstraZeneca
  • Boehringer Ingelheim
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gliflozin Market by Type
  3. 1.2.1 Global Gliflozin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Dapagliflozin
  5. 1.2.3 Empagliflozin
  6. 1.2.4 Canagliflozin
  7. 1.2.5 Other
  8. 1.3 Gliflozin Market by Application
  9. 1.3.1 Global Gliflozin Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Gliflozin Market Dynamics
  1. 2.1 Gliflozin Industry Trends
  2. 2.2 Gliflozin Industry Drivers
  3. 2.3 Gliflozin Industry Opportunities and Challenges
  4. 2.4 Gliflozin Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gliflozin Market Perspective (2021-2032)
  2. 3.2 Global Gliflozin Growth Trends by Region
  3. 3.2.1 Global Gliflozin Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gliflozin Market Size by Region (2021-2026)
  5. 3.2.3 Global Gliflozin Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gliflozin Revenue by Players
  2. 4.1.1 Global Gliflozin Revenue by Players (2021-2026)
  3. 4.1.2 Global Gliflozin Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gliflozin Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gliflozin Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gliflozin Key Players Headquarters & Area Served
  7. 4.4 Global Gliflozin Players, Product Type & Application
  8. 4.5 Global Gliflozin Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gliflozin Market CR5 and HHI
  11. 4.6.3 2025 Gliflozin Tier 1, Tier 2, and Tier 3
5 Gliflozin Market Size by Type
  1. 5.1 Global Gliflozin Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gliflozin Revenue by Type (2021-2032)
  3. 5.3 Global Gliflozin Revenue Market Share by Type (2021-2032)
6 Gliflozin Market Size by Application
  1. 6.1 Global Gliflozin Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gliflozin Revenue by Application (2021-2032)
  3. 6.3 Global Gliflozin Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Janssen Pharmaceutical
  2. 7.1.1 Janssen Pharmaceutical Company Information
  3. 7.1.2 Janssen Pharmaceutical Business Overview
  4. 7.1.3 Janssen Pharmaceutical Gliflozin Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Janssen Pharmaceutical Gliflozin Product Portfolio
  6. 7.1.5 Janssen Pharmaceutical Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Gliflozin Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck Gliflozin Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Gliflozin Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Gliflozin Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Gliflozin Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Gliflozin Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Gliflozin Revenue and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Gliflozin Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Boehringer Ingelheim
  32. 7.6.1 Boehringer Ingelheim Company Information
  33. 7.6.2 Boehringer Ingelheim Business Overview
  34. 7.6.3 Boehringer Ingelheim Gliflozin Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Boehringer Ingelheim Gliflozin Product Portfolio
  36. 7.6.5 Boehringer Ingelheim Recent Developments
  37. 7.7 Astellas Pharma Inc.
  38. 7.7.1 Astellas Pharma Inc. Company Information
  39. 7.7.2 Astellas Pharma Inc. Business Overview
  40. 7.7.3 Astellas Pharma Inc. Gliflozin Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Astellas Pharma Inc. Gliflozin Product Portfolio
  42. 7.7.5 Astellas Pharma Inc. Recent Developments
8 North America
  1. 8.1 North America Gliflozin Revenue (2021-2032)
  2. 8.2 North America Gliflozin Revenue by Type (2021-2032)
  3. 8.2.1 North America Gliflozin Revenue by Type (2021-2026)
  4. 8.2.2 North America Gliflozin Revenue by Type (2027-2032)
  5. 8.3 North America Gliflozin Revenue Share by Type (2021-2032)
  6. 8.4 North America Gliflozin Revenue by Application (2021-2032)
  7. 8.4.1 North America Gliflozin Revenue by Application (2021-2026)
  8. 8.4.2 North America Gliflozin Revenue by Application (2027-2032)
  9. 8.5 North America Gliflozin Revenue Share by Application (2021-2032)
  10. 8.6 North America Gliflozin Revenue by Country
  11. 8.6.1 North America Gliflozin Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gliflozin Revenue by Country (2021-2026)
  13. 8.6.3 North America Gliflozin Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Gliflozin Revenue (2021-2032)
  2. 9.2 Europe Gliflozin Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gliflozin Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gliflozin Revenue by Type (2027-2032)
  5. 9.3 Europe Gliflozin Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gliflozin Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gliflozin Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gliflozin Revenue by Application (2027-2032)
  9. 9.5 Europe Gliflozin Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gliflozin Revenue by Country
  11. 9.6.1 Europe Gliflozin Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gliflozin Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gliflozin Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Gliflozin Revenue (2021-2032)
  2. 10.2 China Gliflozin Revenue by Type (2021-2032)
  3. 10.2.1 China Gliflozin Revenue by Type (2021-2026)
  4. 10.2.2 China Gliflozin Revenue by Type (2027-2032)
  5. 10.3 China Gliflozin Revenue Share by Type (2021-2032)
  6. 10.4 China Gliflozin Revenue by Application (2021-2032)
  7. 10.4.1 China Gliflozin Revenue by Application (2021-2026)
  8. 10.4.2 China Gliflozin Revenue by Application (2027-2032)
  9. 10.5 China Gliflozin Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gliflozin Revenue (2021-2032)
  2. 11.2 Asia Gliflozin Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gliflozin Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gliflozin Revenue by Type (2027-2032)
  5. 11.3 Asia Gliflozin Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gliflozin Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gliflozin Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gliflozin Revenue by Application (2027-2032)
  9. 11.5 Asia Gliflozin Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gliflozin Revenue by Country
  11. 11.6.1 Asia Gliflozin Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gliflozin Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gliflozin Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gliflozin Revenue (2021-2032)
  2. 12.2 SAMEA Gliflozin Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gliflozin Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gliflozin Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gliflozin Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gliflozin Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gliflozin Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gliflozin Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gliflozin Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gliflozin Revenue by Country
  11. 12.6.1 SAMEA Gliflozin Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gliflozin Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gliflozin Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst